NCT06969404

Brief Summary

Nowadays, the tools available to assess the severity of a polytrauma patient in the pre-hospital setting (vital parameters, shock index, MGAP score, Vittel criteria) have their limitations and are sometimes subjective. To date, there are no objective, practical and reproducible tools for triaging these patients. Venous lactataemia also appears to be predictive of poor outcome in severe trauma. However, there are no studies in the literature on capillary lactataemia, which would indicate the potential severity of a polytrauma patient in the pre-hospital setting. However, it is an easily performed, risk-free assay, the results of which can be obtained rapidly at the scene of the accident. The aim of this project is to confirm that, like venous lactataemia, capillary lactataemia can be useful in the pre-hospital phase for predicting a patient's poor outcome. Incorporating this assay into the assessment of potentially severe polytrauma patients in the pre-hospital phase could improve the predictive value of clinical and contextual data and thus enable better referral and management of these patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Feb 2026Dec 2027

First Submitted

Initial submission to the registry

May 2, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

February 7, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2027

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1.4 years

First QC Date

May 2, 2025

Last Update Submit

March 25, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • lactemie value H0

    dosage of capillary lactemia in mmol/L

    at inclusion

  • lactemie value H6

    dosage of capillary lactemia in mmol/L

    6 hours

Study Arms (1)

polytrauma patient

OTHER

capillary blood sampling

Biological: capillary blood sampling

Interventions

capillary blood sampling during the hospital transfert

polytrauma patient

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 years of age
  • Presenting a potentially serious pre-hospital trauma defined by:
  • o A road accident or a fall of more than 2 metres
  • Requiring the dispatch of a SMUR 06 team (mobile emergency and resuscitation service)
  • And transferred to an emergency facility in the Alpes Maritimes with medical assistance.
  • Consent signed (by the patient or a relative) after the event if it is not possible to sign immediately.
  • Pregnant women may also take part in the study without any risk to themselves or their child.

You may not qualify if:

  • Patients with isolated peripheral limb trauma (wrist, elbow, knee, ankle, shoulder)
  • Patients under legal protection (guardianship, curatorship)
  • Patients in cardiorespiratory arrest when taken into care by the SMUR (emergency medical services)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Antibes Hospital

Antibes, 06400, France

NOT YET RECRUITING

Cannes hospital

Cannes, 06000, France

NOT YET RECRUITING

Nice University Hospital

Nice, 06000, France

RECRUITING

MeSH Terms

Conditions

Multiple Trauma

Condition Hierarchy (Ancestors)

Wounds and Injuries

Central Study Contacts

Marta FERNANDES FEIRRERA, PH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2025

First Posted

May 13, 2025

Study Start

February 7, 2026

Primary Completion (Estimated)

June 15, 2027

Study Completion (Estimated)

December 15, 2027

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations